briakinumab - CISMeF

Preferred Label : briakinumab;

MeSH hyponym : ABT-874 antibody, human; BSF 415977; LU 415977; J695;

Is substance : O;

UNII : 978I8M0P8X;

Détails

Origin ID

C544528;

UMLS CUI

C2744325;

ATC code(s)
- briakinumab [ATC Code]
Currated CISMeF NLP mapping
- Briakinumab [NCIt concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
- antibodies, monoclonal, humanized [MeSH Descriptor]
Record concept(s)
- A-796874.0 [MeSH concept]
- ABT-874 [MeSH concept]
- BSF-415977 [MeSH concept]
- J-695 [MeSH concept]
- LU-415977 [MeSH concept]
- WAY-165772 [MeSH concept]
- briakinumab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Briakinumab [NCIt concept]
- briakinumab [ATC Code]
Validated automatic mappings to BTNT
- briakinumab [ATC Code]

Position du mot-clé dans l'(les) arborescence(s) :

Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients